🇺🇸 FDA

Intelligence Platform

Patents

Browse 64 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7189706

C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical c

CAN-FITE BIOPHARMA LTD. · Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141434

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7112574

C2,8-disubstituted adenosine derivatives and their different uses

CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7084127

C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different

CAN-FITE BIOPHARMA LTD. · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7064112

Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

CAN-FITE BIOPHARMA LTD. · Granted Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6911435

Method of treating leukopenia with adenosine

CAN-FITE BIOPHARMA LTD. · Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6790839

Pharmaceutical administration of adenosine agonists

CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6638914

Pharmaceutical administration of adenosine agonists

CAN-FITE BIOPHARMA LTD. · Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6620825

Adenosine A3 receptor antagonists

Takeda Chemical Industries Ltd. · Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6586413

Methods and compositions for reducing ischemic injury of the heart by administering adenos

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579857

Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6436966

Adenosine A3 receptor antagonists

Takeda Chemical Ind., Ltd. · Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6329349

Methods for reducing ischemic injury of the heart via the sequential administration of mon

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6214571

Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosin

The Regents of the University of California · Granted Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6211165

Methods and compositions for reducing ischemic injury of the heart by administering adenos

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6066642

Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their p

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired